GE Healthcare enters licence agreement with Aalborg University  

2005.10.19
UK headquartered GE Healthcare, a USD 15 bn unit of General Electric Company, has entered a licence agreement with Aalborg University on the use of a diagnostic method for a coronary heart disease

UK headquartered GE Healthcare, a USD 15 bn unit of General Electric Company, has entered a licence agreement with Aalborg University on the use of a diagnostic method for a coronary heart disease. Aalborg University's Institute for Health Technology has invented a method, Allqtec, that makes it easier to discover the coronary heart disease Hereditary Long QT Syndrome which is otherwise difficult to diagnose. With Allqtec built into GE healthcare's Muse system for ECG analysis, the disease will automatically be discovered.

The method can also be used to map whether new drugs have a side effect which can provoke a similar disease, Acquired Long QT Syndrome. Aalborg University says that for this application, the method could create great commercial interest because pharmaceutical companies spend large sums on testing the effect of drugs on cardiac rhythm.

Suni Dalbø at Aalborg University comments: "If we gain the necessary approvals and GE Healthcare succeeds in marketing the method, then the agreement is worth quite a lot of money".

GE Healthcare employs more than 43,000 people in more than 100 countries. The company is a world leader in systems for ECG management. Aalborg University is based in northern Jutland, and has around 13,300 students. The news was reported by professional journal Ingeniøren (The Engineer).

Link > GE Healthcare 

Link > Aalborg University 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×